OBJECTIVE: The tonicity-responsive transcription factor, nuclear factor of activated T cells 5 (NFAT5/tonicity enhancer binding protein [TonEBP]), has been well characterized in numerous cell types; however, NFAT5 function in vascular smooth muscle cells (SMCs) is unknown. Our main objective was to determine the role of NFAT5 regulation in SMCs. METHODS AND RESULTS: We showed that NFAT5 is regulated by hypertonicity in SMCs and is upregulated in atherosclerosis and neointimal hyperplasia. RNAi knockdown of NFAT5 inhibited basal expression of several SMC differentiation marker genes, including smooth muscle α actin (SMαA). Bioinformatic analysis of SMαA revealed 7 putative NFAT5 binding sites in the first intron, and chromatin immunoprecipitation analysis showed NFAT5 enrichment of intronic DNA. Overexpression of NFAT5 increased SMαA promoter-intron activity, which requires an NFAT5 cis element at +1012, whereas dominant-negative NFAT5 decreased SMαA promoter-intron activity. Because it is unlikely that SMCs experience extreme changes in tonicity, we investigated other stimuli and uncovered 2 novel NFAT5-inducing factors: angiotensin II, a contractile agonist, and platelet-derived growth factor-BB (PDGF-BB), a potent mitogen in vascular injury. Angiotensin II stimulated NFAT5 translocation and activity, and NFAT5 knockdown inhibited an angiotensin II-mediated upregulation of SMαA mRNA. PDGF-BB increased NFAT5 protein, and loss of NFAT5 inhibited PDGF-BB-induced SMC migration. CONCLUSIONS: We have identified NFAT5 as a novel regulator of SMC phenotypic modulation and have uncovered the role of NFAT5 in angiotensin II-induced SMαA expression and PDGF-BB-stimulated SMC migration.
OBJECTIVE: The tonicity-responsive transcription factor, nuclear factor of activated T cells 5 (NFAT5/tonicity enhancer binding protein [TonEBP]), has been well characterized in numerous cell types; however, NFAT5 function in vascular smooth muscle cells (SMCs) is unknown. Our main objective was to determine the role of NFAT5 regulation in SMCs. METHODS AND RESULTS: We showed that NFAT5 is regulated by hypertonicity in SMCs and is upregulated in atherosclerosis and neointimal hyperplasia. RNAi knockdown of NFAT5 inhibited basal expression of several SMC differentiation marker genes, including smooth muscle α actin (SMαA). Bioinformatic analysis of SMαA revealed 7 putative NFAT5 binding sites in the first intron, and chromatin immunoprecipitation analysis showed NFAT5 enrichment of intronic DNA. Overexpression of NFAT5 increased SMαA promoter-intron activity, which requires an NFAT5 cis element at +1012, whereas dominant-negative NFAT5 decreased SMαA promoter-intron activity. Because it is unlikely that SMCs experience extreme changes in tonicity, we investigated other stimuli and uncovered 2 novel NFAT5-inducing factors: angiotensin II, a contractile agonist, and platelet-derived growth factor-BB (PDGF-BB), a potent mitogen in vascular injury. Angiotensin II stimulated NFAT5 translocation and activity, and NFAT5 knockdown inhibited an angiotensin II-mediated upregulation of SMαA mRNA. PDGF-BB increased NFAT5 protein, and loss of NFAT5 inhibited PDGF-BB-induced SMC migration. CONCLUSIONS: We have identified NFAT5 as a novel regulator of SMC phenotypic modulation and have uncovered the role of NFAT5 in angiotensin II-induced SMαA expression and PDGF-BB-stimulated SMC migration.
Authors: Tadashi Yoshida; Sanjay Sinha; Frédéric Dandré; Brian R Wamhoff; Mark H Hoofnagle; Brandon E Kremer; Da-Zhi Wang; Eric N Olson; Gary K Owens Journal: Circ Res Date: 2003-03-27 Impact factor: 17.367
Authors: Monica Y Lee; Sean M Garvey; Alex S Baras; Julia A Lemmon; Maria F Gomez; Pamela D Schoppee Bortz; Guenter Daum; Renee C LeBoeuf; Brian R Wamhoff Journal: Hum Mol Genet Date: 2009-11-19 Impact factor: 6.150
Authors: Katherine Drews-Elger; M Carmen Ortells; Anjana Rao; Cristina López-Rodriguez; Jose Aramburu Journal: PLoS One Date: 2009-04-21 Impact factor: 3.240
Authors: Kimio Masuda; Riako Masuda; Michel Neidhart; Beat R Simmen; Beat A Michel; Ulf Müller-Ladner; Renate E Gay; Steffen Gay Journal: Arthritis Res Date: 2002-07-17
Authors: Vinicius Tragante; Michael R Barnes; Santhi K Ganesh; Matthew B Lanktree; Wei Guo; Nora Franceschini; Erin N Smith; Toby Johnson; Michael V Holmes; Sandosh Padmanabhan; Konrad J Karczewski; Berta Almoguera; John Barnard; Jens Baumert; Yen-Pei Christy Chang; Clara C Elbers; Martin Farrall; Mary E Fischer; Tom R Gaunt; Johannes M I H Gho; Christian Gieger; Anuj Goel; Yan Gong; Aaron Isaacs; Marcus E Kleber; Irene Mateo Leach; Caitrin W McDonough; Matthijs F L Meijs; Olle Melander; Christopher P Nelson; Ilja M Nolte; Nathan Pankratz; Tom S Price; Jonathan Shaffer; Sonia Shah; Maciej Tomaszewski; Peter J van der Most; Erik P A Van Iperen; Judith M Vonk; Kate Witkowska; Caroline O L Wong; Li Zhang; Amber L Beitelshees; Gerald S Berenson; Deepak L Bhatt; Morris Brown; Amber Burt; Rhonda M Cooper-DeHoff; John M Connell; Karen J Cruickshanks; Sean P Curtis; George Davey-Smith; Christian Delles; Ron T Gansevoort; Xiuqing Guo; Shen Haiqing; Claire E Hastie; Marten H Hofker; G Kees Hovingh; Daniel S Kim; Susan A Kirkland; Barbara E Klein; Ronald Klein; Yun R Li; Steffi Maiwald; Christopher Newton-Cheh; Eoin T O'Brien; N Charlotte Onland-Moret; Walter Palmas; Afshin Parsa; Brenda W Penninx; Mary Pettinger; Ramachandran S Vasan; Jane E Ranchalis; Paul M Ridker; Lynda M Rose; Peter Sever; Daichi Shimbo; Laura Steele; Ronald P Stolk; Barbara Thorand; Mieke D Trip; Cornelia M van Duijn; W Monique Verschuren; Cisca Wijmenga; Sharon Wyatt; J Hunter Young; Aeilko H Zwinderman; Connie R Bezzina; Eric Boerwinkle; Juan P Casas; Mark J Caulfield; Aravinda Chakravarti; Daniel I Chasman; Karina W Davidson; Pieter A Doevendans; Anna F Dominiczak; Garret A FitzGerald; John G Gums; Myriam Fornage; Hakon Hakonarson; Indrani Halder; Hans L Hillege; Thomas Illig; Gail P Jarvik; Julie A Johnson; John J P Kastelein; Wolfgang Koenig; Meena Kumari; Winfried März; Sarah S Murray; Jeffery R O'Connell; Albertine J Oldehinkel; James S Pankow; Daniel J Rader; Susan Redline; Muredach P Reilly; Eric E Schadt; Kandice Kottke-Marchant; Harold Snieder; Michael Snyder; Alice V Stanton; Martin D Tobin; André G Uitterlinden; Pim van der Harst; Yvonne T van der Schouw; Nilesh J Samani; Hugh Watkins; Andrew D Johnson; Alex P Reiner; Xiaofeng Zhu; Paul I W de Bakker; Daniel Levy; Folkert W Asselbergs; Patricia B Munroe; Brendan J Keating Journal: Am J Hum Genet Date: 2014-02-20 Impact factor: 11.025
Authors: Guangze Zhao; Sana Aghakeshmiri; Yankuan T Chen; Huifang M Zhang; Fione Yip; Decheng Yang Journal: Int J Mol Sci Date: 2021-05-04 Impact factor: 5.923